Success Story: EB-1A Approved Without RFE! Our Firm Helped a Senior Research Specialist from China Secure Approval

 

Client’s Testimonial:

“Great communication with customized petition plan.”


On October 23rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Specialist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Senior Research Specialist

Country of Origin: China

State of Residence at the Time of Filing: Maryland

Approval Notice Date: October 23rd, 2025

Processing Time: 16 months, 16 days (Premium Processing Upgrade Requested)


Case Summary:     

The client—a biomedical science researcher with an M.D. and a Ph.D. in medicine—partnered with North America Immigration Law Group (Chen Immigration) to ensure a successful petition outcome from USCIS.

The client is internationally recognized for expertise in neurodevelopment, pediatric neurotoxicity, and anesthesiology. This work is particularly well-known for advancing understanding of how certain anesthetics, such as isoflurane, can affect neurological development — an area of urgent national interest as the U.S. medical community continues to refine safe pediatric clinical practices.

Our team carefully curated and presented compelling documentary evidence to demonstrate the extraordinary nature of the client’s contributions:

  • 18 peer-reviewed journal articles, including 6 first-authored, showcase a strong record of research leadership and innovation.
  • 280 citations, illustrating widespread reliance on the client’s findings by fellow biomedical scientists and clinical researchers worldwide.
  • At least 19 professional peer-review assignments, confirming that respected journals rely on the client’s expertise to evaluate high-impact research in pediatric neurotoxicity and anesthesiology.
  • Funding support connected to the National Institutes of Health (NIH), one of the most prestigious scientific agencies in the United States, further demonstrates the recognized importance of the client’s work.

To bolster the record further, we included four authoritative recommendation letters, each confirming the client’s distinguished reputation and the substantial benefit of continued research in the United States.

Our legal team presented a strong argument establishing that the client’s work directly addresses nationwide healthcare needs, including safer clinical procedures for vulnerable patient populations. The evidence clearly demonstrated that the client is among the small percentage of researchers at the top of the biomedical science field.

We are pleased to share that USCIS approved the client’s EB-1A I-140 petition, acknowledging both the exceptional merit of the case and the critical importance of the client’s research contributions. We are proud to support this talented researcher and look forward to seeing ongoing advancements in pediatric neuroprotection facilitated through continued work in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.


approval_table_2017

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.